RELEASE: Patients For Affordable Drugs Exposes Cancer Medication Price Hikes Disproportionately Harming Black And Latino Communities
NBC News Reports Soaring Medication Costs Force Patients Of Color To Make Impossible Choices
Drug Pricing Is A Health Justice Issue
Price increases disproportionately harm Black and Latino patients
STATEMENT: In A Procedural Ruling, Appeals Court Allows Pharma Trade Association To Proceed With Suit Opposing Medicare Negotiation In Fifth Circuit
District Court Will Now Hear A Suit On The Merits–Like The Industry Has Lost In Every Other Jurisdiction
RELEASE: Patients For Affordable Drugs Files Patient-Focused Amicus Brief Defending The Inflation Reduction Act Against Big Drug Companies’ Challenges
P4AD Counters Industry’s Legal Arguments, Recounts The Sordid History Of Big Pharma’s Opposition To Medicare Negotiation And Tells The Court Of The IRA’s Positive Impact On Millions Of Patients
Rachel Johnston’s Story
Twenty two years ago, I was diagnosed with Crohn’s disease when I was 17 years old. My name is Rachel Johnston and I am a communications and marketing professional living in Los Angeles, California.
RELEASE: Patient Advocates Celebrate Second Anniversary Of The Inflation Reduction Act, Look Ahead To Further Lowered Prices
Patients Champion The Law’s Drug Price Reforms, Share How Their Lowered Rx Prices Will Be Game-changing
ICYMI: Patient Advocate Judy Aiken Introduces President Biden And Vice President Harris At Celebratory Event To Mark Newly Negotiated Lower Drug Prices Through Medicare
Today, following the announcement of the new lower prices negotiated through Medicare – which marked a historic shift in drug pricing policy – P4AD patient advocate Judy Aiken, who takes Enbrel, one of the first 10 negotiated drugs, introduced President Biden and Vice President Harris at an event focused on the new lowered prices.
RELEASE: Biden-Harris Administration Announces First-Ever Lower Medicare Negotiated Drug Prices, Marking Beginning Of New Era In Affordability For Patients On Medicare
Today, the Biden-Harris administration released the results of its first-ever drug price negotiations through Medicare, marking a historic shift in drug pricing policy and promising significant savings for nearly nine million American patients.
